Redeye Feed

2026-05-19 13:14:00 Isofol Medical (Q1 Review): Tailwind despite slower recruitment

2026-05-19 11:17:00 Redeye initiates coverage of 4C Group

2026-05-19 11:14:00 Sprint Bioscience (Q1 Review): Momentum in the business

2026-05-19 11:12:00 Acarix (Q1 Review): Continued US traction and improved cost base

2026-05-19 11:11:00 Smart Eye (Q1 Review): The Lights Go Out and Away We Go

2026-05-18 12:16:00 IDL Diagnostics (Q1 Review): Strong start to 2026

2026-05-18 12:15:00 Fable Media Group (Q1 Review): One Hand on the Trophy

2026-05-18 12:14:00 Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

2026-05-18 12:13:00 Nekkar (Q1 Review): In the Midst of Tender Season

2026-05-18 12:12:00 Siljansvik (Q1 Review): Strong operational momentum and increasing structural optionality

2026-05-18 12:11:00 Relais (Q1 review): Top-line beat driven by winter tailwinds

2026-05-13 15:18:00 Alzinova (Q1 Review): Scientific validation and strategic optionality

2026-05-13 14:47:00 Camurus (Q1 review): Revenues Below Expectations, but Robust Patient Growth

2026-05-13 14:46:00 Cinclus Pharma (Q1 Review): Strengthened finances enables a seamless transition

2026-05-13 14:43:00 Ascelia Pharma (Q1 review): PDUFA-date closing in

2026-05-13 12:09:00 Better Collective (Q1 Preview): Return to organic growth, albeit tempered by sportswin margin headwind

2026-05-13 12:03:00 Redeye initiates coverage of InCoax Networks

2026-05-13 12:01:00 Transtema (Q1 Review): Progress in negotiations

2026-05-13 11:59:00 SciBase (Q1 Review): Progress across key growth drivers

2026-05-13 11:58:00 Coffee Stain Group (Q4 Review): Leaner blend, stronger brew

2026-05-13 11:57:00 CLS (Q1 Review): Well aligned with our expectations

2026-05-13 11:56:00 Moberg Pharma (Q1 Review): APAC Expansion strengthens long-term growth case

2026-05-12 11:47:00 Paxman (Q1 Preview): First CPT1 quarter

2026-05-12 11:43:00 CTEK (Q1 Review): Margin strength and strategic refocus

2026-05-12 11:42:00 W5 Solutions (Q1 Review): Solid order intake derisks growth forecasts

2026-05-12 11:41:00 GomSpace (Q1 Review): Solid outlook with WC headwinds

2026-05-11 15:16:00 Optomed (Q1 Interview): Expecting normalised sales in upcoming quarters

2026-05-11 10:32:00 Redeye Initiates Coverage of KDventures

2026-05-11 10:28:00 Mendus (Q1 review): CML Phase I Initiated

2026-05-11 10:27:00 OXE Marine (Q1 Review): Strong support from main shareholders

2026-05-11 10:26:00 Xbrane Biopharma (Q1 review): Funding outlook improved, FDA decision in November

2026-05-11 10:23:00 Invisio (Q1 Review): Temporary margin headwind, outlook remains solid

2026-05-11 10:22:00 Ferroamp (Q1 Review): Strong growth continues as new partnerships ramp

2026-05-11 10:19:00 InfraCom (Q1 Review): Stop-start turnaround tests patience

2026-05-11 10:17:00 BeammWave (Q1 Review): Deepening projects, missing tapeout details

2026-05-11 10:16:00 Corline Biomedical (Q1 Review): Encouraging signs of commercial acceleration

2026-05-11 10:14:00 Catella (Q1 Review): Bar lowered, setup firms

2026-05-11 09:57:00 Smoltek (Q1 Intervju): Om tekniken, Q1-rapporten och Taiwanresan

2026-05-08 10:23:00 EG7 (Q1 Review): Growing game portfolio supports positive outlook

2026-05-08 10:21:00 Navigo (Q1 Review): Promising start to 2026

2026-05-08 10:20:00 Fractal Gaming Group (Q1 Review): A Necessary Pause Before a Stronger Return

2026-05-08 10:19:00 Truecaller (Q1 Review): Transformation strategy gathers pace

2026-05-08 10:17:00 Freja eID (Q1 Review): Strong momentum in ARR and collaborations

2026-05-08 10:16:00 AlzeCure Pharma (Q1 Review): Advancing toward Phase IIa with NeuroRestore ACD856

2026-05-08 10:15:00 Hexatronic: Data Center expansion and directed rights issue

2026-05-08 10:14:00 Active Biotech (Q1 Review): Intensified Focus on Business Development

2026-05-08 10:12:00 Boreo (Q1 review): Solid organic development, M&A contribution softer

2026-05-08 10:11:00 Alligator Bioscience (Q1 2026 Review): Pragmatic Path to Phase III

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Vem äger bolaget?

Redeye

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden